Replies to post #778 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

fgnoms:
This is not the Biodel board. Such conversations are of topic and should be held elsewhere.
-Fritz

[rkrw]

Through phase 2. I don't expect they'll go through phase 3 without a partner.

I expect biodel to be required to run another trial, so that will delay. I don't consider Biodel serious competition unless they eliminate the injection site reactions it caused.

As I've said before unless a big partner buys in, i'm not sold on this being much bigger than a niche product.